FDA Inspection 892079 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3005680856

The FDA completed an inspection of New York Blood Center Enterprises on August 20, 2014 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 20, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Port Jefferson Station, NY (United States)